Altimmune, Inc. (ALT) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-05-14 00:40:44 ET
Altimmune, Inc. (ALT) Q1 2026 Earnings Call May 13, 2026 8:30 AM EDT
Company Participants
Luis Sanay
Jerome Durso - Chairman, CEO & President
Christophe Arbet-Engels - Chief Medical Officer
Linda Richardson - Chief Commercial Officer
Gregory Weaver - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Altimmune, Inc. (ALT) Q1 2026 Earnings Call Transcript
Altimmune Inc.
NASDAQ: ALT
ALT Trading
-6.94% G/L:
$2.7499 Last:
1,442,185 Volume:
$2.92 Open:
ALT Latest News
May 28, 2026 11:00:00 am
Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48?Week IMPACT Phase 2b Data Presented at EASL 2026
ALT Stock Data
$533,138,746
107,868,919
0.53%
58
N/A
Biotechnology & Life Sciences
Healthcare
US
Gaithersburg
